Ed Silverman
February 11, 2021
EXCERPT:
“‘With a permanent funding source, the board can continue its work finding solutions to address rising drug costs,’ DeMarco said.”
Read full article at https://www.statnews.com/pharmalot/2021/02/11/maryland-drug-prices-veto-hogan/
Last modified: May 3, 2022
